Admission glycemia and markers of inflammation are independent outcome predictors in primary PCI in non-diabetic patients

Minerva Cardioangiologica

Volumn 56, Issue 5, 2008, Pages 445-452

  Corrada, E ^a,b   Cappelleri, A ^a   Belli, G ^a   Genovese, S ^a   Barbaro, C ^a   Gasparini, G ^a   Pagnotta, P ^a   Rossi, M ^a   Zavalloni, D ^a   Presbitero, P ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b Via S Mirocle 9 ^*  (Italy)

Author keywords

Angioplasty, balloon, methods; C reative protein; Glucose, blood; Inflammation; Myocardial infarction; Prognosis

Indexed keywords

C REACTIVE PROTEIN; CREATININE; GLUCOSE;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; PATHOGENESIS; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PROGNOSIS; ST SEGMENT ELEVATION; ST SEGMENT ELEVATION HEART INFARCTION; STRESS; SURVIVAL RATE;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD GLUCOSE; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT ADMISSION; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 55749108012     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000;355:773-8.
2. Stranders I, Diamant M, Van Gelder RE, Spruijt HJ, Twisk JW, Heine RJ et al. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 2004; 164:982-8.
3. Hadjadj S, Coisne D, Mauco G, Ragot S, Duengler F, Sosner P et al. Prognostic value of admission plasma glucose and HbA1c in acute myocardial infarction. Diab Med 2004;21:305-10.
4. Satish Bhadriraju MD, Kausik KR, De Franco AC, De Franco A, Barber K, Bhadriraju P et al. Association with blood glucose and long-term mortality in patients with acute coronary syndrome in the OPUS - TIMI 16 trial. Am J Cardiol 2006;97:1573-7.
5. Ishihara M, Kojima S, Sakamoto T, Asada Y, Tei C, Kimura K et al. Japanese Acute Coronary Syndrome Study Investigators. Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era. Am Heart J 2005;150:814-20.
6. Timmer JR, Van Der Horst ICC, Ottervanger JP, Henriques JP, Hoorntje JC, de Boer MJ et al. Zwolle Myocardial Infarction Study Group. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction. Am Heart J 2004;148:399-404.
7. Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 2005;111:3078-86.
8. Timmer JR, Ottervanger JP, De Boer MJ, Dambrink JH, Hoorntje JC, Gosselink AT et al. Zwolle Myocardial Infarction Study Group. Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in St-segment elevation myocardial infarction. J Am Coll Cardiol 2005;45:999-1002.
9. Iwakura K, Ito H, Ikushima M, Kawano S, Okamura A, Asano K et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 2003;41:1-7.
10. Ceriello A. Acute hyperglicaemia: a 'new' risk factor during myocardial infarction. Eur Heart J 2005;26:328-31.
11. Worthley M, Holmes A, Willoughby S, Kucia A, Heresztyn T, Stewart S et al. The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes mediation by superoxide production, resolution with intensive insulin administration. I Am Coll Cardiol 2007;49:304-10.
12. Marfella R, Siniscalchi M, Esposito K, Sellitto A, De Fanis U, Romano C et al. Effects of stress hyperglycemia on acute myocardial infarction. Diabetes Care 2003;26:3129-35.
13. Biasucci LM. CDC/AHA Workshop on markers of inflammation and cardiovascular disease. Application to clinical and public health practice clinical use of inflammatory markers in patients with cardiovascular diseases. A background paper. Circulation 2004;110:e560-7.
14. Furman MI, Gore JM, Anderson FA, Budaj A, Goodman SG, Avezum A et al. GRACE Investigators. Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings form the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2004;147:42-8.
15. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med 1985;312:932-6.
16. Ishiara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Nishioka K et al. Impact of acute hyperglycaemia on left ventricular function after reperfusion therapy in patients with a first anterior wall acute myocardial infarction. Am Heart J 2003;146:674-8.
17. Bauters C, Ennezat PV, Tricot O, Lauwerier B, Lallemant R, Seadouni H et al. Stress hyperglycaemia is an independent predictor f left ventricular remodelling after first anterior myocardial infarction in non-diabetic patients. Eur Heart J 2007;28:542-52.
18. L'Huillier I, Zeller M, Mock L, Beer JC, Laurent Y, Sicard P et al. Relation of hyperglycemia to ST-segment resolution after reperfusion for acute myocardial infarction (from Observatoire des Infarctus de Cote-d'Or Survey [RICO]). Am J Cardiol 2006;98:167-71.
19. Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 1995;26:57-65.
20. Van Den Berge G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354:449-61.
21. Chauduri A, Janicke D, Wilson MF, Tripathy D, Garg R, Bandyopadhayay A et al. Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction. Circulation 2004;109:849-54.
22. Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Hata T et al. Is admission hyperglycaemia in non-diabetic patients with acute myocardial infarction a surrogate for previously undiagnosed abnormal glucose tolerance? Eur Heart J 2006;27:2413-9.
23. Bartnik M, The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. Eur Heart J 2004;25:1880-90.